APACT: Phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine versus gemcitabine for surgically resected pancreatic adenocarcinoma. 2019 ASCO Annual Meeting. Abstract 4000 - Tempero, M A; Reni, M; Riess, H
Presented June 2, 2019